{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2020"],"condition":["Colorectal cancer"],"disease":["Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2696858"],"location":["China"],"study_start_month":["10"],"repository":["ECRIN MDR"],"study_status":["Not yet recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A phase III, randomized, controlled trial on the benefits of adjuvant chemotherapy after resection of oligometastatic foci in patients after primary colorectal cancer radical resection","description":"Interventions: group with adjuvent chemotherapy:adjuvent chemotherapy;non-adjuvent chemotherapy:Observation and follow-up\nPrimary outcome(s): 3-year disease-free survival\nStudy Design: Parallel","dates":{"creation":"2020-10-15"},"accession":"2696858","cross_references":{"Chinese Clinical Trial Register":["ChiCTR2000036454"]}}